학술논문
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
Document Type
Article
Author
Öcal, O.; Schinner, R.; Ricke, J.; Seidensticker, M.; Schütte, K.; de Toni, E.N.; Malfertheiner, P.; Loewe, C.; van Delden, O.; Vandecaveye, V.; Gebauer, B.; Zech, C.J.; Sengel, C.; Bargellini, I.; Gasbarrini, A.; Sangro, B.; Pech, M.; Kettner, E.; Amthauer, H.; Cwikla, J.; Walecki, J.; Klümpen, H.; Schott, E.; Kolligs, F.; Rosmorduc, O.; Menu, Y.; Leroy, V.; Mayerle, J.; Trumm, C.; Bartenstein, P.; Reiser, M.; Berg, T.; Moche, M.; Bilbao, I.; Gossner, L.; Reimer, P.; Popovic, P.; Stabuc, B.; Piasecki, P.; Podgajny, Z.; Sacco, R.; Peck-Radosavljevic, M.; Lammer, J.; Maleux, G.; Verslype, C.; Rosenberg, C.; Nitsche, D.; Waldenberger, P.; Vergniol, J.; Cassinotto, C.; Yalcin, S.; Peynircioglu, B.; Zavaglia, C.; Rampoldi, A.; Tran, A.; Chevallier, P.; Anty, R.; Trautwein, C.; Kuhl, C.; Grazioli, L.; Vogl, T.; Trojan, J.; Bartolozzi, C.; Iezzi, R.; Bronowicki, J.P.; Palmer, D.; Evans, J.; Sharma, R.; Weir, G.; Hubner, R.; Basu, B.; Ross, P.
Source
In: Cancer Imaging . (Cancer Imaging, December 2022, 22(1))
Subject
Language
English
ISSN
14707330